SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-23-027839
Filing Date
2023-08-11
Accepted
2023-08-11 16:20:49
Documents
5

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 211387
2 ex5-1.htm EX-5.1 10811
3 ex23-2.htm EX-23.2 3529
4 ex107.htm EX-FILING FEES 14665
5 forms-3_001.jpg GRAPHIC 16839
  Complete submission text file 0001493152-23-027839.txt   264777
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273932 | Film No.: 231164437
SIC: 2834 Pharmaceutical Preparations